ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $766,081 | -11.9% | 28,227 | -0.2% | 0.01% | -7.7% |
| Q2 2023 | $869,665 | -14.7% | 28,291 | 0.0% | 0.01% | -27.8% |
| Q1 2023 | $1,019,325 | +17.7% | 28,291 | +29.1% | 0.02% | 0.0% |
| Q4 2022 | $866,041 | -1.7% | 21,914 | 0.0% | 0.02% | -10.0% |
| Q3 2022 | $881,000 | +8.9% | 21,914 | +13.8% | 0.02% | +5.3% |
| Q2 2022 | $809,000 | +7.9% | 19,249 | 0.0% | 0.02% | +18.8% |
| Q1 2022 | $750,000 | -2.2% | 19,249 | 0.0% | 0.02% | 0.0% |
| Q4 2021 | $767,000 | +164.5% | 19,249 | +139.6% | 0.02% | +128.6% |
| Q3 2021 | $290,000 | -12.4% | 8,033 | -0.7% | 0.01% | -12.5% |
| Q2 2021 | $331,000 | -6.0% | 8,087 | 0.0% | 0.01% | -11.1% |
| Q1 2021 | $352,000 | +10.7% | 8,087 | +27.2% | 0.01% | 0.0% |
| Q4 2020 | $318,000 | – | 6,356 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |